0QDS.LSE

Evonik Industries AG

0QDS.LSE, UK

Evonik Industries AG produces and sells specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, and Technology & Infrastructure segments. The Specialty Additives segment offers additives for polyurethane foams; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depressants and viscosity index improvers for coatings and oil and other lubricants for construction machinery and automotive sectors. The Nutrition & Care segment provides D-/l-methionine and lysine for animal nutrition industry; pharmaceutical active ingredients; medical products, including biocompatible and bioresorbable materials for orthopedic and medical applications; cell culture, such as pharmaceutical amino acids and peptides; and system solutions for the cosmetics and detergent industries. The Smart Materials segment offers inorganic materials, including fumed and precipitated silicas and silanes; peroxides for paper and textile industries; specialty catalysts for synthesis and alkoxides; and polymers products, such as polyamide 12, polymer foams, specialty polybutadiene and polyester, and membranes. The Technology & Infrastructure segment provides energy management, integrated plant support and maintenance, process safety and engineering, pipelines, transport management, logistics safety, digital solutions for chemical production, and strategic site development services. The company was founded in 1847 and is based in Essen, Germany.

https://evonik.com

Stock Price

€0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
0QDS.LSE
stock
0QDS.LSE

Evonik (0QDS) Receives a Hold from Barclays The Globe and Mail

Read more →
0QDS.LSE
stock
0QDS.LSE

Goldman Sachs Remains a Sell on Evonik (0QDS) The Globe and Mail

Read more →

Finn Analysis

(Last Updated 2023-06-30)

Health Score

Investors

* Institutions hold a combined 0.00% of the total shares of Evonik Industries AG

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.1

Latest Release

Date

2025-09-30

EPS Actual

-0.2275

EPS Estimate

0.29

EPS Difference

-0.5175

Surprise Percent

-178.4483%

Investing Fit Scorecard

(Last Updated 2023-06-30)

Deep Value
Weak Deep Value(0.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(1.5)
GARP
Not Attractive for GARP(0)
Growth
Weak Growth Prospect(0)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(0)
Quality
Low Quality Business(0.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2023-06-30)

Revenue

€ 0

Cost Of Revenue

€ 0

Gross Profit

€ 0

Operating Expenses

€ 0

Operating Income

€ 0

Interest Expense

€ 0

Pretax Income

€ 0

Net Income

€ 0

Income Tax Expense

€ 0

EBITDA

€ 0

Total Other Income Expense Net

€ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2023-06-30)

Cash

€ 0

Short Term Investments

€ 0

Receivables

€ 0

Inventories

€ 0

Total Current Assets

€ 0

Property Plant Equipment

€ 0

Total Assets

€ 0

Payables

€ 0

Short Term Debt

€ 0

Long Term Debt

€ 0

Total Liabilities

€ 0

Equity

€ 0

Trend

Cash Flow

(Last Updated 2023-06-30)

Net Income

€ 0

Depreciation

€ 0

Change In Working Capital

€ 0

Cash From Operations

€ 0

Capital Expenditures

€ 0

Cash From Investing

€ 0

Cash From Financing

€ 0

Net Change In Cash

€ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.